273
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of Rate of Swelling and Erosion of Verapamil (VRP) Sustained-Release Matrix Tablets

&
Pages 1139-1148 | Published online: 25 Sep 2008

REFERENCES

  • Azarmi S., Farid J., Nokhodchi A., Saravi S. M. B., Valizadeh H. Thermal treating as a tool for sustained-release of indomethacin from Eudragit® RS and RL matrices. Int. J. Pharm. 2002; 246: 171–177, [INFOTRIEVE], [CSA]
  • Bodmeier R., Paeratakul O. Propranolol HCL release from acrylic films prepared from aqueous latexes. Int. J. Pharm. 1990; 59: 197–204, [CSA], [CROSSREF]
  • De Brabander C., Vervaet C., Remon J. P. Development and evaluation of sustained- release mini-matrices prepared via hot melt extrusion. J. Contr. Rel. 2003; 89: 235–247, [CSA], [CROSSREF]
  • Ebube N. K., Hikal A. H., Wyandt C. M., Beer D. C., Miller L. G., Jones A. B. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading and coactive on drug release. Pharm. Dev. Tech. 1997; 2: 161–170, [CSA]
  • Ebube N. K., Jones A. B. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers. Int. J. Pharm. 2004; 272: 19–27, [INFOTRIEVE], [CSA], [CROSSREF]
  • Efentakis, M., Koutlis, A., & Vlachou, M. (2000). Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems. AAPS Pharm. Sci. Tech., 1(4), Article 34, 1–9.http://www.pharmscitech.com
  • Efentakis M., Vlachou M. Evaluation of high molecular weight poly (oxyethylene) (Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatine capsules. Pharm. Dev. Tech. 2000; 5: 339–346, [CSA], [CROSSREF]
  • Elkheshem S. A. Interaction of verapamil hydrochloride with Carbopol® 934P and its effect on the release rate of the drug and water uptake of the polymer matrix. Drug Dev. Ind. Pharm. 2001; 27: 925–934, [CSA], [CROSSREF]
  • Ford J. L., Mitchell K., Rowe P., Armstrong D. J., Eliiot P. N. C., Rostron C., Hogan J. E. Mathematical modelling of drug release from hydroxymethylcellulose matrices: effect of temperature. Int. J. Pharm. 1991; 71: 95–104, [CSA], [CROSSREF]
  • Huber H. E., Dale L. B., Christensen G. L. Utilization of hydrophilic gums for the control of drug release from tablet formulations I. Disintegration and dissolution behaviour. J. Pharm. Sci. 1966; 55: 974–976, [INFOTRIEVE], [CSA], [CROSSREF]
  • Jamzad S., Tutunji L., Fassihi R. Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int. J. Pharm. 2005; 292: 75–85, [INFOTRIEVE], [CSA], [CROSSREF]
  • Koleng J. J., McGinity J. W., Wiber W. R. Carbomer. The Hand book of Pharmaceutical Excipients 4th, R. C. Rowe, P. J. Sheskey, P. J Weller. Informa UK Ltd, Washington, DC 2003; 89–92
  • Kopcha M., Lordi N., Tojo K. J. Evaluation of release from selected thermosoftening vehicles. J. Pharm. Pharmacol. 1991; 43: 382–387, [INFOTRIEVE], [CSA]
  • Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35, [CSA], [CROSSREF]
  • Langer R. S., Peppas N. A. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981; 2: 201–214, [INFOTRIEVE], [CSA], [CROSSREF]
  • Lee P. I., Kim C. J. Probing the mechanisms of drug release from hydrogels. J. Control. Rel. 1991; 16: 229–236, [CSA], [CROSSREF]
  • Lin, A. Y., & Augsburger, L. L. (2001). Study of crystallization of endogenous surfactant in Eudragit® NE 30D-Free films and its influence on drug-release properties of controlled-release diphenyhydramine HCL pellets coated with Eudragit® NE 30D. AAPS Pharmsci., 3(2) Article 14.http://www.pharmsci.org/
  • Meshali M. M., Sayed G. M. E., Said Y. E., Aleem H. M. A. Preparation and evaluation of theophylline sustained-release tablets. Drug Dev. Ind. Pharm. 1996; 22: 373–376, [CSA]
  • Moore J. W., Flanner H. F. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996; 20: 64–74, [CSA]
  • Ratsimbazafy V., Bourret E., Brossard C. Drug release from matrix tablets and minitablets containing glycerides. Pharm. Ind. 1996; 58: 442–446, [CSA]
  • Rigter P. L., Peppas N. A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in form of slabs, spheres, cylinders or discs. J. Contr. Rel. 1987a; 5: 23–36, [CSA], [CROSSREF]
  • Rigter P. L., Peppas N. A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Rel. 1987b; 5: 37–42, [CSA], [CROSSREF]
  • Roy D.S., Rohera B. D. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. Eur. J. Pharm. Sci. 2002; 16: 193–199, [CSA], [CROSSREF]
  • Sadeghi F., Ford J. L., Siahboomi A. R. The influence of drug type on the release profiles from Surelease®-coated pellets. Int. J. Pharm. 2003; 254: 123–135, [INFOTRIEVE], [CSA], [CROSSREF]
  • Surelease®. Aqueous Ethylcellulose Dispersion. Information Sheet/Product Information, Colorcon®, MR/Prodspec/Surelease E-7-19010/12.00-Rev06.01, 2001, Colorcon Ltd: Dartford, Kent, UK
  • Vernaud J. M. Liquid transport controlled release processes in polymeric materials: applications to oral dosage forms. Int. J. Pharm. 1993; 90: 89–94, [CSA], [CROSSREF]
  • Wan L. S. C., Heng P. W. S., Wong L. F. Matrix swelling model describing extent of swelling of HPMC matrices. Int. J. Pharm. 1995; 166: 159–168, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.